FY2025 At a Glance
FY2025 Approval Breakdown
H-1B petitions are split into initial employment (new hires) and continuing employment (extensions/transfers).
Year-over-Year Comparison
FY2024 vs FY2025 petition volumes and approval rates.
| Metric | FY2024 | FY2025 | Change |
|---|---|---|---|
| Initial Approvals | 145 | 167 | +15.2% |
| Initial Denials | 1 | 2 | +100.0% |
| Continuing Approvals | 483 | 557 | +15.3% |
| Continuing Denials | 5 | 6 | +20.0% |
| Total Petitions | 634 | 732 | +15.5% |
| Total Approved | 628 | 724 | +15.3% |
What This Means for H-1B Applicants
Eli Lilly and Company filed 732 H-1B petitions in FY2025, making it a active H-1B sponsor. Petition volume increased 15% year-over-year, suggesting growing demand for H-1B workers.
A 98.9% approval rate is excellent — well above the national average, indicating strong petition quality.
557 continuing employment petitions (extensions and transfers) were filed, with a 98.9% approval rate. This reflects the employer's track record of supporting existing H-1B workers.
Source: USCIS H-1B Employer Data Hub. Data reflects FY2024–FY2025 petition decisions. Not legal advice — consult a qualified immigration attorney for case-specific guidance.Official USCIS Data Hub